A rapid-response economic evaluation of the UK NHS cancer reform strategy breast cancer screening program extension via a plausible bounds approach

Value in Health

Volumn 13, Issue 2, 2010, Pages 215-221

  Madan, Jason ^a   Rawdin, Andrew ^b   Stevenson, Matt ^b   Tappenden, Paul ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Decision analytic model; Economic evaluation; Mammography; Population screening

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MAMMOGRAPHY; MONEY; PARAMETER; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; UNITED KINGDOM;

EID: 77149175619     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00667.x     Document Type: Article

References (25)

1. Department of Health. The NHS Cancer Plan: A Plan for Investment, a Plan for Reform. London : The Stationery Office, 2000.
2. Blanks RG, Moss SM, McGahan CE, et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000 321 : 665 669.
3. Department of Health. Cancer Reform Strategy. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-081006 [Accessed October 9, 2009 SW. Some current issues in breast cancer screening. J Med Screen 2005 12 : 128 133.
4. Karnon J, Goyder E, Tappenden P, et al. A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess 2007 11 : iii xi, 1.
5. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005 353 : 1784 1792.
6. Johnston K. Modelling the future costs of breast screening. Eur J Cancer 2001 37 : 1752 1758.
7. Moss S. Should women under 50 be screened for breast cancer? Br J Cancer 2004 91 : 413 417.
8. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007 146 : 502 510.
9. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res 2002 4 : R11.
10. Habbema JD, Schechter CB, Cronin KA, et al. Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst 2006 Monographs : 122 126.
11. Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006 368 : 2053 2060.
12. Blamey RW, Ellis IO, Pinder SE, et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 2007 43 : 1548 1555.
13. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. University of York: Centre for health economics discussion paper series, 1999.
14. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London : NICE, 2008.
15. NHS Cancer Screening Programmes. Saving lives through screening: NHS Breast Screening Programme Annual Review 2008. Available from: http://www.cancerscreening.nhs.uk/breastscreen/publications/2008review.html [Accessed October 9, 2009].
16. Curtis L. Unit costs of Health and Social Care. Canterbury : University of Kent at Canterbury, Personal Social Services Research Unit, 2008.
17. National Statistics. Mortality statistics - cause. ONS 2006. Report No.: DH32 no. 32.
18. Collins K, Winslow M, Reed M, et al. The views of older women (>70 years) towards mammographic screening: a qualitative study. Eur J Surg Oncol 2008 34 : 1197.
19. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. New Engl J Med 2005 353 : 1773 1783.
20. Neeser K, Szucs T, Bulliard JL, et al. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors. Value Health 2007 10 : 42 53.
21. Ohnuki K, Kuriyama S, Shoji N, et al. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years. Cancer Sci 2006 97 : 1242 1247.
22. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 1997 127 : 955 965.
23. Boyd N, Martin L, Stone J, et al. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002 11 (10 Pt 1 1048 1053.
24. Henderson KD, Bernstein L, Henderson B, et al. Predictors of the timing of natural menopause in the Multiethnic Cohort Study. Am J Epidemiol 2008 167 : 1287 1294.
25. Moss S, Waller M, Anderson TJ, Cuckle H. Randomised controlled trial of mammograhic screening in women from age 40: predicted mortality based on surrogate outcome measures. British Journal of Cancer 2005 92 : 955 960.